The pharmaceutical industry is one of the most data-intensive sectors in the world. From clinical trials and patient records to pharmacovigilance programs and healthcare provider interactions, pharmaceutical companies process enormous volumes of personal and health-related information every day.
As India moves toward stronger privacy regulations under the Digital Personal Data Protection Act (DPDPA), pharmaceutical organizations must rethink how they collect, process, store, share, and secure personal data.
DPDPA compliance is no longer just a legal requirement. It has become a critical business priority that directly impacts:
- Regulatory compliance
- Patient trust
- Research integrity
- Data security
- Business reputation
- Global operations
Pharmaceutical companies that fail to establish robust privacy controls face significant operational, financial, and reputational risks.
In this article, we will explore:
- Why DPDPA matters for pharmaceutical organizations
- Key compliance requirements
- Challenges unique to the pharma sector
- The role of consent management
- Clinical trial data protection
- Third-party risk management
- Best practices for compliance implementation
Why the Pharmaceutical Industry Is Highly Impacted by DPDPA
The pharmaceutical sector handles some of the most sensitive categories of personal information.
This includes:
- Patient medical records
- Clinical trial participant data
- Prescription information
- Laboratory reports
- Genetic and genomic data
- Healthcare provider information
- Employee records
- Adverse event reporting data
Because of the volume and sensitivity of this information, pharmaceutical companies are likely to fall under heightened regulatory scrutiny and may be subject to additional governance obligations depending on the scale and nature of processing.
Unlike many other industries, pharmaceutical organizations frequently share data across multiple stakeholders including:
- Hospitals
- Research institutions
- Contract Research Organizations (CROs)
- Diagnostic laboratories
- Cloud service providers
- Regulatory authorities
This complex ecosystem creates unique privacy and compliance challenges.
Understanding DPDPA in the Pharmaceutical Context
The Digital Personal Data Protection Act establishes rules for processing digital personal data in India.
Under the Act, organizations that determine the purpose and means of processing personal data are classified as Data Fiduciaries. Pharmaceutical companies typically fall into this category because they decide how and why patient, employee, and research data is collected and used.
As Data Fiduciaries, pharmaceutical organizations must:
- Process data lawfully
- Obtain valid consent where required
- Protect personal data
- Enable Data Principal rights
- Maintain accountability
- Implement security safeguards
Importantly, responsibility remains with the Data Fiduciary even when processing activities are outsourced to third parties.
The Types of Personal Data Processed by Pharmaceutical Companies
Pharmaceutical organizations process data throughout the entire drug lifecycle.
Clinical Trial Data
Clinical research programs often collect:
- Medical histories
- Diagnostic reports
- Laboratory results
- Imaging records
- Demographic information
- Follow-up records
- Genetic information
Even when participant identities are partially masked or coded, the data may still qualify as personal data if re-identification remains possible.
Patient and Treatment Data
Pharmaceutical companies often collect:
- Patient support program information
- Medication adherence data
- Disease management records
- Healthcare interactions
This information requires strong privacy controls and appropriate security safeguards.
Healthcare Professional Data
Organizations maintain extensive information about:
- Doctors
- Researchers
- Clinical investigators
- Medical representatives
- Healthcare institutions
This information is also subject to DPDPA requirements.
Employee and Contractor Information
Pharmaceutical companies process personal data related to:
- Employees
- Consultants
- Vendors
- Researchers
- Clinical staff
These records must be managed according to DPDPA principles.
Consent Management: A Core Requirement
Consent forms the foundation of DPDPA compliance.
Pharmaceutical organizations must ensure that individuals understand:
- What data is being collected
- Why it is being collected
- How it will be used
- Who it may be shared with
Consent mechanisms should be:
- Clear
- Specific
- Informed
- Easy to withdraw
The growing focus on consent management frameworks and technologies reflects the importance of enabling Data Principal rights under the DPDPA.
For pharmaceutical companies managing thousands of patients and research participants, manual consent processes are often insufficient.
Modern consent management platforms help organizations:
- Track consent status
- Record consent history
- Manage withdrawals
- Support audit requirements
Protecting Clinical Trial Data
Clinical trials are among the most privacy-sensitive activities in the pharmaceutical sector.
Research participants often provide:
- Health information
- Genetic information
- Behavioral data
- Long-term follow-up records
Organizations must implement safeguards to ensure:
- Confidentiality
- Integrity
- Availability
- Controlled access
Privacy considerations should be embedded into trial design from the beginning.
This includes:
- Data minimization
- Purpose limitation
- Secure storage
- Controlled sharing
Managing Third-Party and CRO Relationships
The pharmaceutical industry relies heavily on external partners.
These include:
- Contract Research Organizations (CROs)
- Laboratories
- Data processors
- Technology providers
- Cloud vendors
While these entities may process personal data on behalf of pharmaceutical companies, the sponsoring organization typically remains responsible for compliance.
Organizations should therefore:
- Review vendor agreements
- Define privacy responsibilities
- Conduct due diligence
- Monitor compliance practices
- Establish breach notification procedures
Strong third-party governance is essential for reducing compliance risk.
Data Discovery and Classification
One of the biggest challenges facing pharmaceutical companies is understanding where personal data exists.
Data may reside across:
- Clinical trial systems
- Laboratory platforms
- Research databases
- Cloud environments
- Email systems
- File servers
- Enterprise applications
Without visibility, compliance becomes difficult.
Data discovery and classification programs help organizations:
- Locate personal data
- Understand data flows
- Identify high-risk assets
- Improve governance
These capabilities are critical for supporting Data Principal rights requests.
Cybersecurity and Data Protection
Pharmaceutical companies are frequent targets of cyberattacks due to the high value of healthcare and research data.
Threats include:
- Ransomware
- Credential theft
- Insider threats
- Data breaches
- Advanced persistent threats
Healthcare and pharmaceutical data often command a premium value among cybercriminals due to their richness and long-term usefulness.
To meet DPDPA obligations, organizations should implement:
- Encryption
- Access controls
- Multi-factor authentication
- Security monitoring
- Threat detection
- Incident response procedures
Cybersecurity and privacy compliance must work together.
Data Principal Rights Under DPDPA
Pharmaceutical organizations must be prepared to support Data Principal rights, including:
Right to Access
Individuals may request information about:
- Personal data being processed
- Processing purposes
- Data sharing practices
Right to Correction
Organizations must correct inaccurate personal information when requested.
Right to Erasure
Data Principals may request deletion of information that is no longer required for the original purpose.
Right to Withdraw Consent
Individuals may withdraw consent and organizations must respond appropriately unless another legal basis permits processing.
Right to Grievance Redressal
Organizations must establish mechanisms to address privacy complaints.
Supporting these rights requires structured operational workflows and strong data governance.
Governance and Accountability Requirements
Effective DPDPA compliance requires organizational commitment.
Pharmaceutical companies should establish cross-functional governance teams involving:
- Legal
- Compliance
- Information Security
- Clinical Operations
- IT
- Human Resources
- Research & Development
Industry guidance highlights the importance of executive sponsorship, privacy leadership, technology investments, and clearly defined accountability structures.
Organizations should also consider:
- Data Protection Officers
- Privacy committees
- Compliance monitoring
- Regular audits
- Employee awareness programs
Key Steps Toward DPDPA Compliance
A structured approach can help pharmaceutical organizations achieve compliance efficiently.
1. Conduct a Data Privacy Assessment
Identify personal data assets, processing activities, and compliance gaps.
2. Build a Data Inventory
Map where personal data is collected, stored, processed, and shared.
3. Implement Consent Management
Deploy systems capable of managing consent lifecycle requirements.
4. Strengthen Security Controls
Implement technical and organizational safeguards.
5. Review Third-Party Contracts
Ensure vendors and processors meet DPDPA expectations.
6. Establish Rights Management Workflows
Create mechanisms for responding to Data Principal requests.
7. Train Employees
Ensure teams understand privacy obligations and responsibilities.
8. Monitor Compliance Continuously
Privacy compliance should be treated as an ongoing governance program rather than a one-time project.
Benefits of DPDPA Compliance for Pharmaceutical Companies
Although compliance requires investment, it delivers significant benefits.
Organizations can achieve:
- Improved patient trust
- Stronger data governance
- Reduced regulatory risk
- Better cybersecurity posture
- Enhanced operational transparency
- Greater audit readiness
- Improved vendor oversight
Compliance can become a competitive advantage in a healthcare ecosystem increasingly focused on privacy and trust.
Final Thoughts
The Digital Personal Data Protection Act is reshaping how pharmaceutical companies manage personal information across research, clinical operations, patient engagement programs, and corporate functions.
For pharmaceutical organizations, DPDPA compliance extends beyond legal obligations. It requires a strategic approach to privacy, security, governance, and accountability.
By implementing strong consent management, data governance, cybersecurity controls, and rights management processes, pharmaceutical companies can not only achieve compliance but also strengthen patient trust and operational resilience.
As healthcare data becomes increasingly digital and interconnected, organizations that prioritize privacy today will be better positioned to navigate future regulatory requirements and evolving cybersecurity threats.
About Securis360 Inc.
Securis360 Inc. helps pharmaceutical and healthcare organizations strengthen data privacy, cybersecurity, and regulatory compliance through DPDPA readiness assessments, data governance programs, risk management, managed security services, cloud security, and compliance consulting. Our experts help organizations build secure, compliant, and resilient digital ecosystems designed for today’s evolving regulatory landscape.